Xiangyan Li
Impact in
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Pharmacology top 1%
- Pharmacological Effects of Natural Compounds
Papers in
-
- Sirtuins and Resveratrol in Medicine 10
- Pharmacology 17
- Pharmacological Effects of Natural Compounds 12
- Co-authors
- Daqing ZhaoWen‐Chin HuangQingxia HuangLeland W.K. ChungYi‐Ting ChenPeizhen HuLiwei SunBoyang Jason Wu
- Journals
- Journal of Nuclear Materials (20 papers)Frontiers in Pharmacology (15 papers)Biomedicine & Pharmacotherapy (8 papers)Journal of Ethnopharmacology (7 papers)Journal of Ginseng Research (5 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Xiangyan Li
172 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Cancer Research 808
- Pharmacology 329
- Biological Psychiatry 76
- Geriatrics and Gerontology 113
- Molecular Biology 1.8k
Countries citing papers authored by Xiangyan Li
This map shows the geographic impact of Xiangyan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyan Li more than expected).
Fields of papers citing papers by Xiangyan Li
This network shows the impact of papers produced by Xiangyan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyan Li. The network helps show where Xiangyan Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiangyan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 2 | |
| 5 | 2024 | 9 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 13 | |
| 8 | 2023 | 18 | |
| 9 | 2023 | 10 | |
| 10 | The impact of oxidative stress-induced mitochondrial dysfunction on diabetic microvascular complications Hit paper breakdown → | 2023 | 103 |
| 11 | 2022 | 2 | |
| 12 | 2022 | 5 | |
| 13 | 2021 | 115 | |
| 14 | 2021 | 17 | |
| 15 | 2020 | 22 | |
| 16 | 2019 | 12 | |
| 17 | 2018 | 14 | |
| 18 | 2014 | 156 | |
| 19 | 2011 | 193 | |
| 20 | Mohnarin of 2008: surveillance results of national bacterial drug resistance. | 2010 | 4 |
About Xiangyan Li
Xiangyan Li is a scholar working on Geriatrics and Gerontology, Pharmacology, Metals and Alloys, Cancer Research and Complementary and alternative medicine, having authored 186 papers that have together received 4.1k indexed citations. Recurring topics across this work include Fusion materials and technologies (33 papers), Ginseng Biological Effects and Applications (32 papers), Nuclear Materials and Properties (31 papers), Autophagy in Disease and Therapy (13 papers), Pharmacological Effects of Natural Compounds (12 papers), Advanced materials and composites (10 papers), Sirtuins and Resveratrol in Medicine (10 papers) and Cancer, Lipids, and Metabolism (9 papers). The work is most often cited by research in Cancer Research (808 citations), Pharmacology (329 citations), Biological Psychiatry (76 citations), Geriatrics and Gerontology (113 citations) and Molecular Biology (1.8k citations). Xiangyan Li has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Daqing Zhao, Wen‐Chin Huang, Qingxia Huang, Leland W.K. Chung, Yi‐Ting Chen, Peizhen Hu, Liwei Sun, Boyang Jason Wu, Wenxiu Qi and Hongyu Qi. Their work appears in journals such as Journal of Nuclear Materials, Frontiers in Pharmacology, Biomedicine & Pharmacotherapy, Journal of Ethnopharmacology and Journal of Ginseng Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.